Fielmann Group AG (FLMNY)
OTCMKTS
· Delayed Price · Currency is USD
12.16
-0.28 (-2.25%)
At close: May 8, 2025
Fielmann Group AG Revenue
Fielmann Group AG had revenue of 592.93M EUR in the quarter ending March 31, 2025, with 12.06% growth. This brings the company's revenue in the last twelve months to 2.33B, up 15.20% year-over-year. In the year 2024, Fielmann Group AG had annual revenue of 2.26B with 14.88% growth.
Revenue (ttm)
2.33B EUR
Revenue Growth
+15.20%
P/S Ratio
2.03
Revenue / Employee
95.59K EUR
Employees
24,363
Market Cap
5.11B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.26B | 293.22M | 14.88% |
Dec 31, 2023 | 1.97B | 211.85M | 12.04% |
Dec 31, 2022 | 1.76B | 80.90M | 4.82% |
Dec 31, 2021 | 1.68B | 249.22M | 17.44% |
Dec 31, 2020 | 1.43B | -91.81M | -6.04% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |